$157.90
At close: May 2 EDT
$158.50
0.600.38%
Pre-Market: 4:35 AM EDT
Comments
Loading...
Inspire Medical Systems Analyst Ratings and Price Targets | NYSE:INSP | Benzinga
Inspire Medical Systems Inc has a consensus price target of $247 based on the ratings of 19 analysts. The high is $350 issued by Lake Street on August 2, 2023. The low is $175 issued by Stifel on April 21, 2025. The 3 most-recent analyst ratings were released by Stifel, Keybanc, and RBC Capital on April 21, 2025, April 21, 2025, and April 15, 2025, respectively. With an average price target of $202 between Stifel, Keybanc, and RBC Capital, there's an implied 27.44% upside for Inspire Medical Systems Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stifel
Keybanc
RBC Capital
Truist Securities
Baird
1calculated from analyst ratings
Analyst Ratings for Inspire Medical Systems
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/21/2025 | Buy Now | 10.41% | Stifel | Jonathan Block70% | $190 → $175 | Maintains | Hold | Get Alert |
| 04/21/2025 | Buy Now | 36.28% | Keybanc | Tim Rezvan49% | $234 → $216 | Maintains | Overweight | Get Alert |
| 04/15/2025 | Buy Now | 35.65% | RBC Capital | Shagun Singh59% | $260 → $215 | Maintains | Outperform | Get Alert |
| 02/11/2025 | Buy Now | 48.26% | Truist Securities | Richard Newitter74% | $250 → $235 | Maintains | Buy | Get Alert |
| 02/11/2025 | Buy Now | 64.04% | RBC Capital | Shagun Singh59% | $260 → $260 | Reiterates | Outperform → Outperform | Get Alert |
| 02/11/2025 | Buy Now | 56.47% | Baird | Mike Polark55% | $252 → $248 | Maintains | Outperform | Get Alert |
| 02/11/2025 | Buy Now | 23.03% | Wells Fargo | Larry Biegelsen67% | $198 → $195 | Maintains | Equal-Weight | Get Alert |
| 02/11/2025 | Buy Now | 38.8% | Morgan Stanley | Kallum Titchmarsh30% | $230 → $220 | Maintains | Overweight | Get Alert |
| 02/10/2025 | Buy Now | 47% | Piper Sandler | Adam Maeder63% | $260 → $233 | Maintains | Overweight | Get Alert |
| 01/24/2025 | Buy Now | 47.63% | Keybanc | Brett Fishbin54% | $236 → $234 | Reiterates | Overweight → Overweight | Get Alert |
| 01/21/2025 | Buy Now | 19.87% | Stifel | Jonathan Block70% | $200 → $190 | Maintains | Hold | Get Alert |
| 11/20/2024 | Buy Now | 60.88% | B of A Securities | Bob Hopkins45% | $220 → $255 | Upgrade | Neutral → Buy | Get Alert |
| 11/05/2024 | Buy Now | 64.04% | RBC Capital | Shagun Singh59% | $260 → $260 | Reiterates | Outperform → Outperform | Get Alert |
| 11/05/2024 | Buy Now | 64.04% | Piper Sandler | Adam Maeder63% | $255 → $260 | Reiterates | Overweight → Overweight | Get Alert |
| 11/05/2024 | Buy Now | 26.18% | Stifel | Jonathan Block70% | $170 → $200 | Reiterates | Hold → Hold | Get Alert |
| 11/05/2024 | Buy Now | 24.92% | Wells Fargo | Larry Biegelsen67% | $187 → $198 | Maintains | Equal-Weight | Get Alert |
| 11/05/2024 | Buy Now | 58.99% | Baird | Mike Polark55% | $240 → $252 | Maintains | Outperform | Get Alert |
| 09/30/2024 | Buy Now | 51.42% | Truist Securities | Richard Newitter74% | $217 → $240 | Reiterates | Buy → Buy | Get Alert |
| 09/10/2024 | Buy Now | 24.29% | Leerink Partners | Mike Kratky64% | $167 → $197 | Maintains | Market Perform | Get Alert |
| 08/07/2024 | Buy Now | 48.9% | Keybanc | Brett Fishbin54% | $278 → $236 | Maintains | Overweight | Get Alert |
| 08/07/2024 | Buy Now | 64.04% | RBC Capital | Shagun Singh59% | $260 → $260 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2024 | Buy Now | 26.18% | Baird | Mike Polark55% | $220 → $200 | Maintains | Outperform | Get Alert |
| 07/16/2024 | Buy Now | 36.91% | Truist Securities | Richard Newitter74% | $280 → $217 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | 32.49% | Morgan Stanley | Kallum Titchmarsh30% | $250 → $210 | Maintains | Overweight | Get Alert |
| 06/24/2024 | Buy Now | 7.26% | Stifel | Jonathan Block70% | $210 → $170 | Maintains | Hold | Get Alert |
| 06/03/2024 | Buy Now | 16.72% | B of A Securities | Bob Hopkins45% | $225 → $185 | Maintains | Neutral | Get Alert |
| 05/08/2024 | Buy Now | 60.88% | Piper Sandler | Adam Maeder63% | $250 → $255 | Maintains | Overweight | Get Alert |
| 04/19/2024 | Buy Now | 79.81% | RBC Capital | Shagun Singh59% | → $285 | Initiates | → Outperform | Get Alert |
| 03/27/2024 | Buy Now | 57.73% | Mizuho | Anthony Petrone67% | $250 → $250 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | 76.66% | Truist Securities | Richard Newitter74% | → $280 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2024 | Buy Now | 57.73% | Morgan Stanley | Kallum Titchmarsh30% | → $250 | Initiates | → Overweight | Get Alert |
| 02/07/2024 | Buy Now | 76.66% | Truist Securities | Richard Newitter74% | $265 → $280 | Maintains | Buy | Get Alert |
| 02/07/2024 | Buy Now | 57.73% | Mizuho | Anthony Petrone67% | $225 → $250 | Maintains | Buy | Get Alert |
| 02/06/2024 | Buy Now | 75.39% | Keybanc | Brett Fishbin54% | → $278 | Initiates | → Overweight | Get Alert |
| 01/19/2024 | Buy Now | 54.57% | Jefferies | — | → $245 | Initiates | → Buy | Get Alert |
| 01/02/2024 | Buy Now | 32.49% | Stifel | Jonathan Block70% | → $210 | Downgrade | Buy → Hold | Get Alert |
| 12/22/2023 | Buy Now | 64.04% | Truist Securities | Richard Newitter74% | $240 → $260 | Maintains | Buy | Get Alert |
| 12/13/2023 | Buy Now | 17.98% | Wells Fargo | Larry Biegelsen67% | → $187 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/08/2023 | Buy Now | 32.49% | Stifel | Jonathan Block70% | $250 → $210 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | 35.65% | Mizuho | Anthony Petrone67% | $300 → $215 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | 51.42% | Truist Securities | Richard Newitter74% | $260 → $240 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | 54.57% | Wells Fargo | Larry Biegelsen67% | $330 → $245 | Maintains | Overweight | Get Alert |
| 11/07/2023 | Buy Now | 57.73% | Stifel | Jonathan Block70% | $350 → $250 | Maintains | Buy | Get Alert |
| 10/17/2023 | Buy Now | 14.2% | JP Morgan | Robbie Marcus67% | $340 → $181 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | 0.32% | Leerink Partners | Mike Kratky64% | → $159 | Initiates | → Market Perform | Get Alert |
| 10/02/2023 | Buy Now | 114.51% | Truist Securities | Richard Newitter74% | → $340 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2023 | Buy Now | 103.15% | UBS | Danielle Antalffy61% | $405 → $322 | Maintains | Buy | Get Alert |
| 08/24/2023 | Buy Now | 114.51% | Truist Securities | Richard Newitter74% | $363 → $340 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 114.51% | JP Morgan | Robbie Marcus67% | $300 → $340 | Maintains | Overweight | Get Alert |
| 08/02/2023 | Buy Now | 120.82% | Lake Street | Frank Takkinen36% | $305 → $350 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 129.02% | Truist Securities | Richard Newitter74% | $380 → $363 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 108.2% | Wells Fargo | Larry Biegelsen67% | $315 → $330 | Maintains | Overweight | Get Alert |
| 07/19/2023 | Buy Now | 139.75% | Truist Securities | Richard Newitter74% | $360 → $380 | Maintains | Buy | Get Alert |
| 07/19/2023 | Buy Now | 134.07% | Baird | Mike Polark55% | → $371 | Initiates | → Outperform | Get Alert |
| 07/13/2023 | Buy Now | 120.82% | Stifel | Jonathan Block70% | $300 → $350 | Maintains | Buy | Get Alert |
| 07/05/2023 | Buy Now | 123.97% | B of A Securities | Bob Hopkins45% | $310 → $355 | Maintains | Buy | Get Alert |
| 06/12/2023 | Buy Now | 89.27% | Mizuho | Anthony Petrone67% | → $300 | Reiterates | Buy → Buy | Get Alert |
| 06/08/2023 | Buy Now | 114.51% | Piper Sandler | Adam Mizrahi45% | $315 → $340 | Maintains | Overweight | Get Alert |
| 06/08/2023 | Buy Now | 111.36% | Keybanc | Matthew Mishan53% | $321 → $335 | Maintains | Overweight | Get Alert |
| 05/18/2023 | Buy Now | 127.13% | Piper Sandler | Adam Mizrahi45% | $335 → $360 | Maintains | Overweight | Get Alert |
| 05/03/2023 | Buy Now | 91.8% | UBS | Danielle Antalffy61% | $300 → $304 | Maintains | Buy | Get Alert |
| 05/03/2023 | Buy Now | 98.74% | Piper Sandler | Adam Mizrahi45% | $305 → $315 | Maintains | Overweight | Get Alert |
| 05/03/2023 | Buy Now | 102.52% | Keybanc | Matthew Mishan53% | $303 → $321 | Maintains | Overweight | Get Alert |
| 04/14/2023 | Buy Now | 89.27% | Mizuho | Anthony Petrone67% | → $300 | Initiates | → Buy | Get Alert |
| 04/13/2023 | Buy Now | 89.27% | Mizuho | Anthony Petrone67% | → $300 | Initiates | → Buy | Get Alert |
| 04/11/2023 | Buy Now | 89.27% | Stifel | Jonathan Block70% | $290 → $300 | Maintains | Buy | Get Alert |
| 03/29/2023 | Buy Now | 89.27% | UBS | Danielle Antalffy61% | → $300 | Initiates | → Buy | Get Alert |
| 02/08/2023 | Buy Now | 108.2% | Truist Securities | Richard Newitter74% | $310 → $330 | Maintains | Buy | Get Alert |
| 02/08/2023 | Buy Now | 89.27% | JP Morgan | Robbie Marcus67% | $271 → $300 | Maintains | Overweight | Get Alert |
| 02/08/2023 | Buy Now | 92.43% | Piper Sandler | Adam Maeder63% | $300 → $305 | Maintains | Overweight | Get Alert |
| 01/31/2023 | Buy Now | 95.58% | Truist Securities | Richard Newitter74% | $308 → $310 | Maintains | Buy | Get Alert |
| 01/26/2023 | Buy Now | 89.27% | Piper Sandler | Adam Maeder63% | $285 → $300 | Maintains | Overweight | Get Alert |
| 01/13/2023 | Buy Now | 91.17% | Keybanc | Matthew Mishan53% | $287 → $303 | Maintains | Overweight | Get Alert |
| 12/20/2022 | Buy Now | 94.32% | Truist Securities | Richard Newitter74% | $270 → $308 | Maintains | Buy | Get Alert |
| 12/13/2022 | Buy Now | — | Goldman Sachs | Amit Hazan57% | — | Upgrade | Neutral → Buy | Get Alert |
| 12/13/2022 | Buy Now | 81.07% | Keybanc | Matthew Mishan53% | → $287 | Initiates | → Overweight | Get Alert |
| 10/17/2022 | Buy Now | 51.42% | Truist Securities | Richard Newitter74% | $280 → $240 | Maintains | Buy | Get Alert |
| 08/03/2022 | Buy Now | 79.81% | Piper Sandler | Adam Maeder63% | $310 → $285 | Maintains | Overweight | Get Alert |
| 06/10/2022 | Buy Now | 57.73% | Truist Securities | Richard Newitter74% | $296 → $250 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Inspire Medical Systems (INSP) stock?
The latest price target for Inspire Medical Systems (NYSE:INSP) was reported by Stifel on April 21, 2025. The analyst firm set a price target for $175.00 expecting INSP to rise to within 12 months (a possible 10.41% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Inspire Medical Systems (INSP)?
The latest analyst rating for Inspire Medical Systems (NYSE:INSP) was provided by Stifel, and Inspire Medical Systems maintained their hold rating.
When was the last upgrade for Inspire Medical Systems (INSP)?
The last upgrade for Inspire Medical Systems Inc happened on November 20, 2024 when B of A Securities raised their price target to $255. B of A Securities previously had a neutral for Inspire Medical Systems Inc.
When was the last downgrade for Inspire Medical Systems (INSP)?
The last downgrade for Inspire Medical Systems Inc happened on January 2, 2024 when Stifel changed their price target from N/A to $210 for Inspire Medical Systems Inc.
When is the next analyst rating going to be posted or updated for Inspire Medical Systems (INSP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inspire Medical Systems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inspire Medical Systems was filed on April 21, 2025 so you should expect the next rating to be made available sometime around April 21, 2026.
Is the Analyst Rating Inspire Medical Systems (INSP) correct?
While ratings are subjective and will change, the latest Inspire Medical Systems (INSP) rating was a maintained with a price target of $190.00 to $175.00. The current price Inspire Medical Systems (INSP) is trading at is $158.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
